Literature DB >> 14744375

[Clinical analysis of pediatric SARS cases in Beijing].

Zhong-zhi Li1, Kun-ling Shen, Xin-miao Wei, Hui-ling Wang, Jin Lu, Hong Tian, Guo-qiang Sun, Jin-jin Zeng, Ying-hui Hu, Shun-ying Zhao, Ju Yin, Xue-li Feng, Zai-fang Jiang, Yong-hong Yang.   

Abstract

OBJECTIVE: To study clinical characteristics of pediatric SARS cases in Beijing.
METHODS: Eighteen pediatric cases with SARS diagnosed on admission were analyzed. The cases were admitted to Beijing Children's Hospital and Ditan Hospital (pediatric ward) from April 8 to May 12.
RESULTS: The 18 children aged 5 months to 15 years (10 male and 8 female) had epidemiologically linked findings. Fourteen cases had close contact with SARS patients. Four cases were living in the community where adult SARS patients were found. All the 18 patients but one presented with fever and cough. Most of them had high fever, 2 cases had bradycardia, 2 had diarrhea, and another 2 had tachypnea. Malaise and headache were noted only in 3 cases respectively which were much less frequently seen than in adult patients. Symptoms and signs of the children were much less severe and aggressive than adults cases. Thirteen children had chest radiographic consolidation. Of them, 9 cases had progressive changes after admission, then improved quickly. We did not find significant lower hemoglobin and platelet levels. Most patients had leukopenia and lymphopenia. Serologic test was performed for 15 cases and 8 were positive for SARS virus-IgG and 6 for IgM antibody. Of the 4 cases who had close contact with SARS adults and without chest radiograph abnormal findings, 3 were negative for SARS virus-antibodies. Part of the patients had temporary abnormality of myocardial enzyme and liver function. All these children finally had rapid improvement on chest radiograph. The patients were treated with antiviral agents and corticosteroid. Only two cases required oxygen therapy. No child needed assisted ventilation and no death, nor lung fibrosis occurred. After hospitalization, all patients were improved and discharged when this paper was being written. The average hospital stay of these patients was 14.6 days (6 - 22 days).
CONCLUSION: Compared with adults, pediatric SARS patients seemed to have their own clinical characteristics. The disease in children had lower severity and infectivity than that in adults. The mechanisms of the disease in children should be studied in well-designed clinical trials. Cases like the 4 children who had close contact with SARS adult patients but without chest radiographic changes deserve further studies with the help of more reliable and sensitive etiologic tests.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14744375

Source DB:  PubMed          Journal:  Zhonghua Er Ke Za Zhi        ISSN: 0578-1310


  10 in total

1.  [Asymptomatic SARS-CoV-2 infection in children: a clinical analysis of 20 cases].

Authors:  Jun Chen; Xian-Feng Wang; Pei-Fa Zhang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-05

2.  Children's vaccines do not induce cross reactivity against SARS-CoV.

Authors:  Yang Yu; Huali Jin; Ze Chen; Qingling L Yu; Yijie J Ma; Xiaolin L Sun; Bin Wang
Journal:  J Clin Pathol       Date:  2007-02       Impact factor: 3.411

Review 3.  SARS: systematic review of treatment effects.

Authors:  Lauren J Stockman; Richard Bellamy; Paul Garner
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

4.  Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase.

Authors:  D Xu; Z Zhang; L Jin; F Chu; Y Mao; H Wang; M Liu; M Wang; L Zhang; G F Gao; F S Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-03       Impact factor: 3.267

Review 5.  A review of treatment modalities for Middle East Respiratory Syndrome.

Authors:  Yin Mo; Dale Fisher
Journal:  J Antimicrob Chemother       Date:  2016-09-01       Impact factor: 5.790

6.  Effect of coronavirus infection on the human heart: A scoping review.

Authors:  Jamie Sy Ho; Paul A Tambyah; Andrew Fw Ho; Mark Yy Chan; Ching-Hui Sia
Journal:  Eur J Prev Cardiol       Date:  2020-05-18       Impact factor: 7.804

7.  Clinical characteristics of children with COVID-19: a rapid review and meta-analysis.

Authors:  Zijun Wang; Qi Zhou; Chenglin Wang; Qianling Shi; Shuya Lu; Yanfang Ma; Xufei Luo; Yangqin Xun; Weiguo Li; Muna Baskota; Yinmei Yang; Hui Zhai; Toshio Fukuoka; Hyeong Sik Ahn; Myeong Soo Lee; Zhengxiu Luo; Enmei Liu; Yaolong Chen
Journal:  Ann Transl Med       Date:  2020-05

Review 8.  Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue.

Authors:  Kun-Ling Shen; Yong-Hong Yang
Journal:  World J Pediatr       Date:  2020-02-05       Impact factor: 9.186

Review 9.  Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement.

Authors:  Kunling Shen; Yonghong Yang; Tianyou Wang; Dongchi Zhao; Yi Jiang; Runming Jin; Yuejie Zheng; Baoping Xu; Zhengde Xie; Likai Lin; Yunxiao Shang; Xiaoxia Lu; Sainan Shu; Yan Bai; Jikui Deng; Min Lu; Leping Ye; Xuefeng Wang; Yongyan Wang; Liwei Gao
Journal:  World J Pediatr       Date:  2020-02-07       Impact factor: 9.186

Review 10.  Pharmacological treatments of COVID-19.

Authors:  Adeleh Sahebnasagh; Razieh Avan; Fatemeh Saghafi; Mojataba Mojtahedzadeh; Afsaneh Sadremomtaz; Omid Arasteh; Asal Tanzifi; Fatemeh Faramarzi; Reza Negarandeh; Mohammadreza Safdari; Masoud Khataminia; Hassan Rezai Ghaleno; Solomon Habtemariam; Amirhosein Khoshi
Journal:  Pharmacol Rep       Date:  2020-08-20       Impact factor: 3.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.